Redosing study… [Study As­sess­ment]

posted by luvblooms  – India, 2011-06-18 13:47 (5490 d 00:17 ago) – Posting: # 7153
Views: 12,918

Hello EM,

❝ Yes, this spells trouble. Highly variable drug 'in some patients'. Or highly variable patients among your study population.


Yes!!!! But again issue is how to identify the highly variable volunteer.

❝ I can't imagine a solution in the concrete situation, especially not when non-parametrics are discouraged.


Now planning to put a day housing before the study to minimize the physiological based variation. Let's see.

Luv

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
323 visitors (0 registered, 323 guests [including 31 identified bots]).
Forum time: 14:05 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5